AU2001236207A1 - Powder formulation - Google Patents
Powder formulationInfo
- Publication number
- AU2001236207A1 AU2001236207A1 AU2001236207A AU3620701A AU2001236207A1 AU 2001236207 A1 AU2001236207 A1 AU 2001236207A1 AU 2001236207 A AU2001236207 A AU 2001236207A AU 3620701 A AU3620701 A AU 3620701A AU 2001236207 A1 AU2001236207 A1 AU 2001236207A1
- Authority
- AU
- Australia
- Prior art keywords
- powder formulation
- excipient
- particle size
- size distribution
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000006069 physical mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0031—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200550A EP1129705A1 (de) | 2000-02-17 | 2000-02-17 | Pulverformulierung zur Inhalation |
EP00200550 | 2000-02-17 | ||
PCT/NL2001/000133 WO2001060341A1 (en) | 2000-02-17 | 2001-02-19 | Powder formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001236207A1 true AU2001236207A1 (en) | 2001-08-27 |
Family
ID=8171037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001236207A Abandoned AU2001236207A1 (en) | 2000-02-17 | 2001-02-19 | Powder formulation |
Country Status (7)
Country | Link |
---|---|
US (1) | US7344734B2 (de) |
EP (2) | EP1129705A1 (de) |
AT (1) | ATE271383T1 (de) |
AU (1) | AU2001236207A1 (de) |
DE (1) | DE60104399T2 (de) |
PT (1) | PT1257260E (de) |
WO (1) | WO2001060341A1 (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
TWI224515B (en) | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
DE10129703A1 (de) * | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
GB0128148D0 (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
WO2003089036A1 (en) | 2002-04-19 | 2003-10-30 | 3M Innovative Properties Company | A spacer for inertial removal of the non-respirable fraction of medicinal aerosols |
KR20050056222A (ko) * | 2002-09-30 | 2005-06-14 | 아쿠스피어 인코포레이티드 | 흡입용 지속 방출형 다공성 미세입자 |
US6962006B2 (en) * | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
EP1488819A1 (de) | 2003-06-16 | 2004-12-22 | Rijksuniversiteit te Groningen | Trockenpulverinhalator und Verfahren zur pulmonalen Inhalation von Trockenpulver |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
JP2007533634A (ja) * | 2003-09-30 | 2007-11-22 | アキュスフィア, インコーポレイテッド | 注射、経口、または局所用の徐放性医薬製剤 |
GB0326632D0 (en) | 2003-11-14 | 2003-12-17 | Jagotec Ag | Dry powder formulations |
JP2007533387A (ja) | 2004-04-21 | 2007-11-22 | イノベータ バイオメド リミテッド | 吸入器 |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
SE530006C2 (sv) * | 2004-06-18 | 2008-02-05 | Mederio Ag | Inhalator som använder balja |
WO2006023849A2 (en) | 2004-08-20 | 2006-03-02 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
JP4990142B2 (ja) | 2004-08-23 | 2012-08-01 | マンカインド コーポレイション | 薬物送達のためのジケトピペラジン塩、ジケトモルホリン塩、又はジケトジオキサン塩 |
CN104177448A (zh) | 2005-02-10 | 2014-12-03 | 葛兰素集团有限公司 | 使用预分选技术制备乳糖的方法以及由此形成的药物制剂 |
EP1904219A4 (de) | 2005-07-15 | 2011-07-27 | Map Pharmaceuticals Inc | Teilchenbildungsverfahren |
IN2014DN09128A (de) | 2005-09-14 | 2015-07-10 | Mannkind Corp | |
GB0525254D0 (en) | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
WO2007070843A2 (en) * | 2005-12-15 | 2007-06-21 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for oral administration |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
GB0622818D0 (en) * | 2006-11-15 | 2006-12-27 | Jagotec Ag | Improvements in or relating to organic compounds |
KR20100044225A (ko) | 2007-07-21 | 2010-04-29 | 알바니 몰레큘라 리써치, 인크. | 5-피리디논 치환된 인다졸 |
EP2020249A1 (de) * | 2007-08-01 | 2009-02-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Inhalator |
CA2722611A1 (en) | 2007-11-21 | 2009-05-28 | Decode Genetics Ehf | Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
ES2523580T3 (es) | 2008-01-11 | 2014-11-27 | Albany Molecular Research, Inc. | Piridoindoles substituidos con (1-Azinona) |
ES2546025T3 (es) * | 2008-01-24 | 2015-09-17 | Vectura Delivery Devices Limited | Inhalador |
EP3281663B8 (de) | 2008-06-13 | 2022-09-21 | MannKind Corporation | Atemluftbetriebener trockenpulverinhalator zur verabreichung von medikamenten |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
BRPI0914308B8 (pt) | 2008-06-20 | 2021-06-22 | Mannkind Corp | sistema de inalação |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
GB201020130D0 (en) * | 2010-11-26 | 2011-01-12 | Vectura Delivery Devices Ltd | Inhaler |
GB0818476D0 (en) * | 2008-10-09 | 2008-11-12 | Vectura Delivery Device Ltd | Inhaler |
WO2010059836A1 (en) | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Substituted aza-bridged bicyclics for cardiovascular and cns disease |
WO2010060876A1 (de) * | 2008-11-28 | 2010-06-03 | Boehringer Ingelheim International Gmbh | Dispergierverfahren zur bestimmung der partikelhaftkraft |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
NZ594768A (en) | 2009-01-26 | 2013-02-22 | Israel Inst Biolog Res | Bicyclic heterocyclic spiro compounds |
WO2010105094A1 (en) | 2009-03-11 | 2010-09-16 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
WO2010144789A2 (en) | 2009-06-12 | 2010-12-16 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
DE102009037840B4 (de) * | 2009-08-18 | 2012-08-16 | Gamptec Gmbh | Inhalationsvorrichtung und Verfahren zur Inhalation eines Wirkstoffs aus einer Kapsel |
WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
GB0919465D0 (en) * | 2009-11-06 | 2009-12-23 | Norton Healthcare Ltd | Airflow adaptor for a breath-actuated dry powder inhaler |
AU2011271097B2 (en) | 2010-06-21 | 2014-11-27 | Mannkind Corporation | Dry powder drug delivery system and methods |
EP2694402B1 (de) | 2011-04-01 | 2017-03-22 | MannKind Corporation | Blisterverpackung für pharmakartuschen |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
CA2852536A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
WO2014012069A2 (en) | 2012-07-12 | 2014-01-16 | Mannkind Corporation | Dry powder drug delivery systems and methods |
EP2911690A1 (de) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalierbare influenza-impfstoffzusammensetzungen und verfahren |
KR102499439B1 (ko) | 2013-03-15 | 2023-02-13 | 맨카인드 코포레이션 | 미세결정성 디케토피페라진 조성물 및 방법 |
BR112015033065B1 (pt) * | 2013-07-03 | 2022-12-20 | Biopraxis Research Aie | Nanopartícula de lipídio; composição farmacêutica; e uso da nanopartícula de lipídio |
CA2918369C (en) | 2013-07-18 | 2021-06-29 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
SG11201700621XA (en) | 2014-07-25 | 2017-02-27 | Agency Science Tech & Res | Antibiotic compositions for treating bacterial infections |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
ES2841933T3 (es) | 2014-10-31 | 2021-07-12 | Univ Monash | Formulación en polvo |
WO2019183245A1 (en) | 2018-03-20 | 2019-09-26 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
CA3111275A1 (en) | 2018-09-06 | 2020-03-12 | Innopharmascreen Inc. | Methods and compositions for treatment of asthma or parkinson's disease |
CN113508111A (zh) | 2018-12-31 | 2021-10-15 | 西奈山伊坎医学院 | 激酶抑制剂化合物和组合物及使用方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1242211A (en) | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
US5048227A (en) * | 1988-05-05 | 1991-09-17 | Junya Okubo | Method of cultivating agaricus blazei mushroom |
DE4140689B4 (de) | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung |
DE4211475A1 (de) * | 1991-12-14 | 1993-06-17 | Asta Medica Ag | Pulverinhalator |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
JP2001505557A (ja) * | 1996-11-15 | 2001-04-24 | パソジェネシス コーポレイション | 肺感染を処置するための、純粋な生物学的活性コリスチン、その成分、およびコリスチン処方物 |
GB9626263D0 (en) * | 1996-12-18 | 1997-02-05 | Innovata Biomed Ltd | Powder inhaler |
JP3051073B2 (ja) * | 1996-12-20 | 2000-06-12 | 住友林業株式会社 | 抗腫瘍活性物質 |
SE9700133D0 (sv) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
WO1998035546A1 (fr) * | 1997-02-12 | 1998-08-20 | Imb Kabushiki Gaisha | Methode de culture de sporophores d'agaricus blazei dans un lit artificiel de culture de champignons |
US6465218B1 (en) * | 1997-04-08 | 2002-10-15 | Japan Applied Microbiology Research Institute Co., Ltd. | Biologically active substance and process of preparing the same |
EP0876814A1 (de) | 1997-05-07 | 1998-11-11 | "PHARLYSE", Société Anonyme | Trägerstoff für Trockenpulverinhalator, Verfahren zu dessen Herstellung und diesen enthaltende Arzneimittel |
US5980918A (en) * | 1997-10-24 | 1999-11-09 | Brennen Medical, Inc. | β-D-glucan topical composition |
GB9820746D0 (en) * | 1998-09-23 | 1998-11-18 | Pharmax Limited | Micronised pharmaceutical compositions |
US6120772A (en) * | 1998-10-08 | 2000-09-19 | Hitoshi Ito | Oral drugs for treating AIDS patients |
-
2000
- 2000-02-17 EP EP00200550A patent/EP1129705A1/de not_active Withdrawn
-
2001
- 2001-02-19 AT AT01908465T patent/ATE271383T1/de not_active IP Right Cessation
- 2001-02-19 EP EP01908465A patent/EP1257260B1/de not_active Revoked
- 2001-02-19 DE DE60104399T patent/DE60104399T2/de not_active Expired - Lifetime
- 2001-02-19 WO PCT/NL2001/000133 patent/WO2001060341A1/en active IP Right Grant
- 2001-02-19 PT PT01908465T patent/PT1257260E/pt unknown
- 2001-02-19 AU AU2001236207A patent/AU2001236207A1/en not_active Abandoned
-
2002
- 2002-08-19 US US10/223,707 patent/US7344734B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1257260A1 (de) | 2002-11-20 |
PT1257260E (pt) | 2004-12-31 |
ATE271383T1 (de) | 2004-08-15 |
EP1129705A1 (de) | 2001-09-05 |
DE60104399D1 (de) | 2004-08-26 |
DE60104399T2 (de) | 2005-09-08 |
EP1257260B1 (de) | 2004-07-21 |
US7344734B2 (en) | 2008-03-18 |
US20030053960A1 (en) | 2003-03-20 |
WO2001060341A1 (en) | 2001-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001236207A1 (en) | Powder formulation | |
IL114596A0 (en) | Pharmaceutical compositions for administration by inhalation | |
AU2002316820A1 (en) | Powder inhaler formulations | |
EP1312357A3 (de) | Pharmazeutische Formulierungen für Trockenpulverinhalatoren | |
YU68199A (sh) | Farmaceutske formulacije koje sadrže vorikonazol | |
AU5677099A (en) | New solid dose form of nanoparticulate naproxen | |
GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
WO2001049274A3 (en) | Methods for pulmonary delivery of interleukin-2 | |
MXPA04007427A (es) | Formulaciones de azitromicina granuladas por via seca. | |
CA2385890A1 (en) | Controlled release compositions comprising nimesulide | |
WO2004108162A3 (en) | Controlled release pharmaceutical composition | |
WO2005025535A8 (en) | Methods for preparing pharmaceutical compositions | |
MY127350A (en) | Flash-melt oral dose formulations | |
WO2002015959A3 (en) | Compounds and compositions for delivering active agents | |
WO2005065639A3 (en) | Novel pharmaceutical compositions | |
WO2002100338A3 (en) | Compound and composition for delivering active agents | |
BE2016C017I2 (de) | ||
YU72802A (sh) | Farmaceutske smeše koje sadrže oligosaharide, novi oligosaharidi i njihovo dobijanje | |
WO1999058527A3 (en) | Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient | |
WO2002041879A3 (en) | Antidiabetic compositions containing a biguanide and a sulfonamide | |
WO2002020056A3 (en) | Methods and compositions for producing a neurosalutary effect in a subject | |
WO2005087192A3 (en) | Salmeterol inhalation formulations | |
WO2001053322A3 (en) | Aerothricin analogs, their preparation and use |